Pirbuterol
From Wikipedia, the free encyclopedia
 |
|
|
Pirbuterol
|
|
| Systematic (IUPAC) name | |
| (R,S)a6-{[(1 ,1 -Dimethylethyl)amino] methyl}-3-hydroxy-2,6-pyridinedimethanol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H20N2O3 |
| Mol. mass | 240.30 g/mol 300.3 g/mol (acetate) |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status | |
| Routes | Inhalational |
Pirbuterol (trade name: Maxair) is a beta-2 adrenergic bronchodilator used in the treatment of asthma, available (as perbuterol acetate) as a breath-activated metered-dose inhaler ("autohaler").
Contents |
[edit] Clinical use
- Asthma - preventative/maintenance medicine
- Asthma - "rescue" medicine for reversal of acute asthma attack
[edit] Mode of Action
[edit] Adverse Effects
[edit] Source/External Link
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||
|
|||||
